
























The name Twenty Nine refers to the 29 scientists present in the fifth Solvay Conference in 1927, established a turning point in the world of science.
Dominique is a faculty member in the Department of Biotechnology at MiraCosta College, San Diego, USA. She teaches courses on experimental design, upstream and downstream bioprocessing, and biostatistics. Dominique has mentored undergraduate students in research projects ranging from the ‘optimization of chemical cell disruption of Nannochloropsis oculata’ to the ‘development of inquiry-based projects for teaching design of experiments.’
“The future of lab work centers around accessibility. It’s an absolute must that laboratory software developers be committed to accessible design.”
Microbiology, food, pathogens
Jonas is completing his Bachelor’s in microbiology at the Aix-Marseille University in France. He is also Co-President of the International Genetically Engineered Machine (iGEM) local chapter since 2019.
"The Lab of the Future will be environment-friendly and inclusive. Sharing between team member and with other teams will be easier. Data will be stored online and we could have access to them at anytime and anywhere."
Synthetic biology, molecular biology, iGEM
Funsho is a PhD student in the laboratory group of Prof. Niels Voigt, Institute of Pharmacology and Toxicology, University Medical Centre Gottingen, Germany. His research is aimed at deciphering the roles of ion channels in the pathophysiology of cardiovascular disorders, particularly atrial fibrillation, utilizing cellular electrophysiological (Patch clamp), epifluorescence microscopy and molecular biology techniques.
"An effortless ability to simultaneously observe and document transient experimental changes in real-time, transcending physical limitations, is my forecast for a futuristic laboratory."
Pharmacology, cell culture, electrocardiogram (ECG), toxicology, physiology, microscopy, molecular biology
Javier is completing his PhD in microbiology at the Barcelona Institute for Global Health in the University of Barcelona. His research focuses on the discovery of new antimicrobials to help fight antimicrobial resistance.
“I believe the lab of the future will be a space where science can be performed without hurdles thanks to technologies such as 5G, the Internet of Things and LabTwin. These technologies will speed up research and reduce the amount of time it takes to develop cutting edge projects.”
Microbiology, food, pathogens
Maria-Isabel is completing her PhD in molecular biology at San Diego State University and the University of California, San Diego. Her research focuses on understanding how the viruses that infect bacteria, called phages for short, persist in, or escape from, their bacterial host. Her work combines molecular microbiology, genomics, biochemistry, and microbial ecology. Twice a year, she organizes the student innovation workshop for the Viral Information Institute.
“In the Lab of the Future, we will be able to access protocols for experiments in various fields of science from different institutions, and the details of their development and optimization will be readily available.”
Microbiology, phages, pathogens, corals
Goutham is a Scientist at the Philipps University of Marburg. His research leverages state of the art technologies like viral vectors and complicated brain surgeries to uncover the molecular basis of alpha synucleinopathies in neurodegeneration and Parkinson's disease. Goutham is an early adopter of LabTwin. He found our platform after searching for smart, hands-free, digital applications to help him collect lab data and share with colleagues in real-time.
“The future of scientific laboratories should be smart and remotely controllable. I believe new age technologies like Artificial Intelligence and Voice Recognition will revolutionize the way scientific experiments are done, enhancing accuracy and reproducibility.”
Virus, neuroscience, electrophysiology
Aline is founder and CSO of San Diego-based company VITAbolus. She is a recognized cell therapy expert with over 20 years of experience and recently sold her first stem cell technology. Now with VITAbolus, her goal is to democratize cell therapy by developing a proprietary, inexpensive, and simple to take stem cell pill.
“The Lab of the Future is virtual. You can program, record and analyze experiments from anywhere. Colleagues can also follow from anywhere and comment or suggest modifications such as adding different controls etc. Many experiments will occur in simulated or surrogate settings rather than requiring living or animal test subjects.”
Stem cells, diagnostics, cancer
Annie Voigt is a biochemist, behavioral biologist and neuroscientist. She is currently pursuing her PhD in neuroscience at Charité Berlin and the Humboldt University Berlin, Germany. Her work focuses on the formation of memories.
Neuroscience, psychology
Katrine is currently completing a PhD in microbiology at Aarhus University and the University of Copenhagen in Denmark. Her work focuses on mobile genetic elements, such as plasmids and bacteriophages, and their importance in a variety of ecosystems. She also works to overcome biases in retrieval of mobilomes and viromes.
“In the future, wet lab work will hopefully be way more efficient with streamlined technology to help scientists take correct notes, set timers and check protocols while the work is happening and not afterwards.”
Phages, probiotics, metagenomics, mobilome
After completing a Master thesis at Bayer HealthCare, Dennis Kwiatkowski is now a PhD student at the Freie Universität Berlin and a research associate in the Institute for Medical Physics and Biophysics at the Charité Universitätsmedizin in Berlin, Germany. Dennis studies G-protein coupled receptors, is a freelance lecturer and has even founded a microbrewery.
"The lab of the future is personalized, interactive and frictionless and will connect great minds AND great technologies."
Ernesto Diaz-Flores is an Assistant Adjunct Professor at University of California, San Francisco where he uses a novel multiparametric flow cytometry platform to discover drug targets for high-risk subtypes of childhood leukemia.
"The lab of the future will be more interdisciplinary, collaborative and standarized. Labs will include several digital components, share databases and integrate larger computational analyses."
Leukemia, cancer, biochemistry, in-vivo and ex-vivo models, immunology
Sonali is a 4th year PhD student at the Central European Institute of Technology in the Czech Republic. Her research mainly focuses on understanding the network of non-coding and coding RNAs in chronic lymphocytic leukemia (CLL). She mainly works with cell lines and primary cells isolated from CLL patients.
“The lab of the future is automated with artificial intelligence (AI)-driven tools to record and set up experiments.”
Cell biology, cancer, leukemia, RNA
Liliana’s passion is developing sustainable environmental solutions for our society. She recently completed her PhD at the Max Planck Institute of Molecular Plant Physiology where her work focused on protein and metabolic engineering to obtain novel enzymes for sustainable projects. During her PhD, Liliana organized scientific and cultural events such as the 2019 Plant and People Conference and mental health initiatives in Potsdam.
“The lab of the future is a place where scientific knowledge and stored data are easy to use and share, therefore increasing efficiency during lab work and streamlining publication of results.”
Plant Physiology, Enzymes, Proteins, Molecular Biology
Sagar is a PhD student at the Central Department of Microbiology at Tribhuvan University in Nepal and the Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) in Saarbrucken, Germany. His research focuses on isolating novel microorganisms from the soil for use in drug discovery. He has a special interest in digital marketing and is an avid blogger.
“In the future, scientists will be able to access any lab from anywhere in the world using modern innovative technologies such as robotics and artificial intelligence.”
Drug discovery, Actinomycetes, Myxobacteria, AI, Science Communication, Biotech
Kiara is a postdoctoral researcher at Jena University Hospital (Uniklinikum Jena) in Germany. She studies interactions between proteins and neurons during cortical development in mammals. She is passionate about how man-made chemicals affect brain development and has been the lead organizer of TEDxFSUJena since 2016.
“The lab of the future will allow several groups across the globe to work closely together and share experimental data in real time.”
Toxicology, embryology, neurology, proteins, biochemistry
After gaining experience in R&D project management and lab automation, Maryna now works with organoid cultures and high-throughput technologies such as single-cell analysis. She focuses on the interface between innovative biomedical experiments and cutting-edge data science.
“The lab of the future is digital and high-throughput thereby enhancing the performance of scientists doing challenging research and making their routines much more pleasant.”
Single-cell analysis, Biotech, Computational Biology, Bioinformatics, Organoids
Steffen has a PhD in microbiology from the Technical University Hamburg. After 8 years of experience in QC labs at Bayer, he is very interested in the field of lab digitalization. Steffen is now is Dean of the Life Sciences and Technology Department at the Beuth University of Applied Sciences Berlin, where he also teaches microbiology. He uses game-based teaching and learning in the lab and also conducts research in the field of diagnostics.
“Some of us were born yesterday and cooperatively train the young people of today for tomorrow. For me, the challenge is responsible and sustainable teaching.”
QC, microbiology, digitization, diagnostics
Prathibha completed her PhD in molecular biology at the University of Würzburg, Graduate School of Life Sciences (GSLS) and now works as a postdoctoral researcher at the Interfaculty Institute of Cell Biology (IFIZ) at the University of Tübingen. She studies how metabolism and cell cycle regulation are linked in eukaryotes. Her research combines metabolomics, biochemistry and live-cell imaging.
“The lab of the future will embrace greater transparency and scientific communication as well as interconnectivity between research groups across the globe. Now is the time for strengthening interdisciplinary research!”
Bhavik is a Senior Scientist working for the Research & Development Department of U.S. Pharmacopeia in India. His research focuses on improving public health by supporting the development of affordable medicines. Bhavik’s work specifically focuses on liposomal injection formulations for novel therapies to treat cancer, blood infections and post-surgical pain management.
“The lab of the future will be fully robotized, connected to various information systems and driven towards innovation. AI will simplify research and it's scalability will be huge.”
Pharma, biotech, cancer, sepsis, surgery, AI
Ofer is a postdoctoral fellow in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco where he leverages many types of ’omics analysis methods to study the role of short coding and non-coding DNA sequences in both normal development and disease pathogenesis.
“Free from the chain of notebooks and printouts, the lab of the future is seamless, workgroup-oriented, cloud-based, and above all accessible from your mobile device.”
Genomics, proteomics, transcriptomics, disease, bioengineering, genome
Gloria is a 4th year immunology PhD student at the Center for Regenerative Therapies in TU Dresden where she develops protocols for single immune cell analysis, uses R programming language to analyze gene expression and organizes the TEDxDresden idea conference.
“The lab of the future is fast, efficient and sustainable—an environment where scientists can record multiple parameters while working on cell culture and flow cytometry, with no need for additional paperwork.”
Flow cytometry, RNA, programming, Immunology, gene expression, TED, sequencing, single-cell, biomedicine
Pedro is a physicist and neuroscientist pursuing a Masters at the Charité University Hospital in Berlin. He integrates synthetic biology, artificial intelligence and nanotechnology tools to dissect the cell signaling networks that sculpt neurogenesis in the mammalian brain. Furthermore, he is a frequent contributor to a number of magazines, writing articles on transatlantic relations, Latin American politics and gender studies.
“The lab of the future will focus on better human-centric designs. Scientific experiments will be performed from anywhere by taking advantage of better in silico models linked to automated facilities. This will provide more freedom allowing scientists to harness their creativity, increase productivity and global connections without being limited by physical borders and the demand for being on site.”
CRISPR, optogenetics, iPS cells, in-vivo, pathogenesis, neuropsychiatry, animal models, human-centered design
Laura is a medical advisor and Latin America Regional Manager at BluSense Diagostics, a Danish medtech company where she supervises the execution of clinical trials. She obtained her PhD in cell biology at the University of Amsterdam, where she studied the dividing bacterial cell as a promising target for novel antibiotics. Laura is also a fundraising volunteer at Techo, a civil rights non-profit organization in Colombia.
“For me, the lab of the future is hands-free, allows data reporting in real time and enables scientists to perform experiments with speed and efficiency.”
Molecular biology, Microbiology, Genetics, Transcriptomics, fluorescence microscopy, antibiotics
Ana-Maria is a molecular biologist in Berlin. Her field of research is haematology and oncology. She aims for a better understanding of brain cancer and brain metastasis. The brain is the human’s best-protected organ. Still, cancer manages to find a way into the brain. One of Ana-Maria’s goals is to decode how cancer cells manage to bypass the checkpoints of the immune system and which molecular mechanism cancer cells use to succeed into the central nervous system. Apart from science Ana-Maria enjoys languages and connecting with interesting people around the world.
Agata Mikołajczyk is a doctor in veterinary medicine working as a researcher at the Department of Biochemistry and Molecular Biology in Wrocław University of Environmental and Life Sciences.
© 2019-2021 All Rights Reserved. LabTwin® is a registered trademark of LabTwin GmbH.